Raleigh, NC, United States of America

William C Blackwell, Iii

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Aktis Oncology, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William C Blackwell, Iii. Retrieved from https://idiyas.com/inventor/william-c-blackwell-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of William C. Blackwell, III

Introduction

William C. Blackwell, III is an accomplished inventor based in Raleigh, NC. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His work focuses on innovative solutions for diagnosing and treating diseases associated with specific targets.

Latest Patents

William C. Blackwell, III holds a patent for "Nectin-4 binding miniproteins, conjugates and uses thereof." This patent includes polypeptides and conjugates, including radionuclide conjugates, which are useful in compositions and methods for treating, diagnosing, monitoring, and imaging diseases associated with the expression of Nectin-4.

Career Highlights

He is currently associated with Aktis Oncology, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating new therapeutic options for patients suffering from various conditions.

Collaborations

William has collaborated with notable colleagues, including Michael Lawrence Doligalski and Paul L. Feldman, contributing to a dynamic research environment that fosters innovation.

Conclusion

William C. Blackwell, III exemplifies the spirit of innovation in biotechnology through his patent and ongoing work at Aktis Oncology, Inc. His contributions are vital for the advancement of medical treatments and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…